Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Altmueller, Janine Dr.med. (29) Blankenstein, Thomas Prof. Dr. (20) Bunse, Mario Dr. (1) Harabula, Izabela-Cezara (1) Kammertöns, Thomas Dr. (7) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (2) Lupianez Garcia, Dario Jesus Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Willimsky, Gerald Dr. (6) (-) Daniel, Peter Prof. Dr. (1) (-) Fischer, Cornelius Dr. (1) (-) Uckert, Wolfgang Prof. Dr. (4) Bioinformatik der Genregulation (1) Experimentelle Ultrahochfeld-MR (7) Genetik metabolischer und reproduktiver Störungen (4) Genom-Editierung & Krankheitsmodelle (2) (-) Genomics (1) Immunregulation und Krebs (3) Magnetic Resonance (7) Mobile DNA (2) (-) Molekulare Immunologie und Gentherapie (5) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Transgenics (2) Zelluläre Neurowissenschaften (4) 2002 (1) 2003 (4) 2004 (1) 2005 (4) 2006 (1) 2007 (2) 2008 (1) 2010 (1) (-) 2011 (3) 2014 (1) 2015 (4) (-) 2016 (3) 2017 (2) 2018 (4) 2019 (3) 2020 (3) 2021 (1) 2022 (5) 2023 (2) 6 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Fischer, Cornelius Dr.Uckert, Wolfgang Prof. Dr.GenomicsMolekulare Immunologie und Gentherapie 20112016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein 07. Oktober 2016 / J Proteome Res Efficient application of de novo RNA assemblers for proteomics informed by transcriptomics T. Luge C. Fischer S. Sauer 17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau 01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein
07. Oktober 2016 / J Proteome Res Efficient application of de novo RNA assemblers for proteomics informed by transcriptomics T. Luge C. Fischer S. Sauer
17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein